Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
GenomeDx Biosciences, a leader in the field of urologic cancer genomics, today announced that Noridian GBA, a Medicare Administrative Contractor...
GenomeDx Biosciences, a leader in the field of urologic cancer genomics, today announced that Palmetto GBA, a Medicare Administrative Contractor...
GenomeDx Biosciences, a leader in the field of urologic cancer genomics, announced today that Cigna® issued positive medical policy coverage for...
GenomeDx Biosciences and Pathnostics today announced the launch of the next generation Guidance testing for patients suffering from simple cystitis,...
GenomeDx Biosciences, a leader in the field of urologic cancer genomics, today announced that it will present results from seven studies featuring...
GenomeDx Biosciences, a leader in the field of urologic cancer genomics, today announced a research collaboration with Janssen Pharmaceuticals. As...
GenomeDx Biosciences, a leader in the field of urologic cancer genomics, today announced that its Decipher® Prostate Biopsy and Decipher Prostate RP...
GenomeDx Biosciences, a leader in the field of urologic cancer genomics, today announced that its Decipher® Prostate Biopsy, Prostate RP and Bladder...
GenomeDx Biosciences, a leader in the field of urologic cancer genomics, today announced that it will present results from three studies featuring...
GenomeDx Biosciences, a leader in the field of urologic genomics, and Pathnostics, a provider of comprehensive and dynamic pathology services, today...
GenomeDx Biosciences, a leader in the field of urologic cancer genomics, today announced approval by the New York State Clinical Laboratory...
GenomeDx Biosciences today announced results from three recent publications demonstrating the clinical validity of the Decipher® Prostate Cancer...
GenomeDx Biosciences, a leader in the field of urologic cancer genomics, today announced that it will present results from two studies featuring the...
GenomeDx Biosciences, a leader in the field of urologic cancer genomics, today announced a collaboration with Color to offer its Color Test, a...
GenomeDx Biosciences, a leader in the field of urologic cancer genomics, today announced that a genomic signature commonly used with breast cancer...
GenomeDx Biosciences today announced the launch of its Decipher® Bladder Cancer Classifier (Decipher Bladder) following the publication of a study...
GenomeDx Biosciences, a leader in the field of urologic cancer genomics, today announced the appointment of Michael Rodriguez as the company's chief...
GenomeDx Biosciences today announced that seven abstracts featuring the company's Decipher® Genomics Resource Information Database (Decipher GRID®),...
GenomeDx Biosciences today announced the publication of interim results from an ongoing prospective clinical study of the impact of the Decipher®...
GenomeDx Biosciences today announced that six abstracts featuring Decipher GRID® (Genomics Resource Information Database) and Decipher® Prostate...
GenomeDx Biosciences today announced the initiation of a prospective, randomized controlled trial evaluating the utility of its Decipher® Prostate...
GenomeDx Biosciences today announced that oral and poster presentations featuring Decipher® Prostate Cancer Classifier tests, Genomics Resource...
GenomeDx Biosciences today announced that it has entered into a research collaboration with Astellas, a leading global pharmaceutical company, to...
GenomeDx Biosciences today announced the first study that demonstrates the ability of the Decipher® Prostate Cancer Classifier Biopsy Test (Decipher...
GenomeDx Biosciences today announced that ten presentations featuring Decipher® Prostate and Bladder data will be presented at the 17th Annual...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.